News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
HANNAH ALISON L.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| HANNAH ALISON L. (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
| 07/12/2023 |
4
| HANNAH ALISON L. (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| HANNAH ALISON L. (Chief Medical Officer) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 22,500 shares
@ $0
Granted 135,000 options to buy
@ $4.13, valued at
$557.6k
|
|
| 10/26/2021 |
4
| HANNAH ALISON L. (Chief Medical Officer) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $5.34, valued at
$213.6k
Granted 30,000 options to buy
@ $0 |
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2020 |
4
| HANNAH ALISON L. (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 2,698 shares
@ $0
Granted 3,448 options to buy
@ $28.54, valued at
$98.4k
|
|
| 02/05/2020 |
4
| HANNAH ALISON L. (Chief Medical Officer) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $7.71, valued at
$1.9M
|
|
| 02/05/2020 |
3
| HANNAH ALISON L. (Chief Medical Officer) has filed a Form 3 on CytomX Therapeutics, Inc. |
| 09/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2019 |
4
| HANNAH ALISON L. (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 3,419 shares
@ $0
Granted 4,269 options to buy
@ $22.52, valued at
$96.1k
|
|
| 06/05/2018 |
4
| HANNAH ALISON L. (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 15,564 shares
@ $0
Granted 3,017 options to buy
@ $11.6, valued at
$35k
|
|
| 10/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/01/2016 |
4
| HANNAH ALISON L. (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 5,072 restricted stock units
@ $0
Granted 8,333 options to buy
@ $9.11, valued at
$75.9k
|
|
| 05/04/2016 |
4
| HANNAH ALISON L. (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 2,150 shares
@ $7.15, valued at
$15.4k
|
|
|
|